Michail Popov, CEO studied computer science, medicine and bioinformatics. Before founding ABCD the 27 year old held mission-critical research, technical and advisory positions in academic and industry environments in the fields of medical devices, kinetic modelling, distributed IT-systems, genetics, biostatistics and artificial intelligence.

Dr. Gudrun Lewin, Scientific Board studied medicine. After basic and clinical research in the fields of biorhythms, neurophysiology, transfusiology, free radicals and antioxidants at the Medical Faculty (Charité) of the Humboldt University, Berlin, she became head of the Research Institute for Antioxidant Therapy (F.A.T.) in 1994.

Prof. Igor Popov, Scientific Board studied physics and medicine. He researched free radicals, antioxidants and chemiluminescence in the departments of medical immunology, neurophysiology, anaesthesiology and kidney transplantation of the Charité and is chief scientist of F.A.T. since 1994.


* G. Lewin and I. Popov authored more than 200 scientific publications, lectures and patents and wrote Habilitation Thesis "The Antioxidative Homeostasis in Human Organism" in 1988

** F.A.T. developed the first commercialy available system for the measurement of antioxidants, based on photosensibilized chemiluminescence, and sold it to Analytik Jena AG in 2000